Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/11/2009
PIL Femodene

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/06/2008 and displayed until 06/11/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 15/09/2006 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 17/03/2005 and displayed until 15/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/02/2005 and displayed until 17/03/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change from the BAN of the active substance to the rINN
Updated on 22/10/2002 and displayed until 25/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 11/01/2002 and displayed until 22/10/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 12/09/2000 and displayed until 11/01/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/07/2000 and displayed until 12/09/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 15/03/2000 and displayed until 06/07/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  ethinylestradiol
  gestodene